BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
The TIENS Group Co., Ltd. is a multinational conglomerate, integrating industrial capital, business capital and financial capital with its scope of business covering biotechnology, health management, hotel and tourism industry, education & training, e-commerce and finance
Acute Care Technology The Acute Care Technology division of ZOLL Medical Corporation develops and delivers innovative lifesaving products and software solutions to EMS, hospital, public safety, and military customers globally. Products include AEDs, trauma kits, ventilators,
We are hiring a Pharmacovigilance Medical Manager (m/f/d) Contract type: remote contract based in Germany. You would be a contributor to a Global Team with collective responsibility for regulatory activities associated with global pharmacovigilance including electronic
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Vendor Business Unit Director Remote Germany Full time About the Role The Vendor Business Unit Director is the strategic leader responsible for the overall performance, growth, execution and market development of the assigned business unit within
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Account Executive DACH, LE GBS Gartner for HR provides CHROs and HR executives with actionable, objective insights that drive smarter decisions and stronger performance on an organization’s mission-critical priorities. At Gartner, we guide the leaders who
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)